Loading clinical trials...

Self-regulation for Older Adults With Asthma Through Remote Education | Clinical Trials | Clareo Health

COMPLETEDNA

Self-regulation for Older Adults With Asthma Through Remote Education

NCT05722834•University of Michigan

Summary

This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for asthma. The purpose of this study is to implement and evaluate an asthma self-management intervention through multiple locations in the United States that is tailored to the challenges older adults face and is based on an individual behavioral theory of change. Eligible participants will be enrolled and participate for six weeks in the SOAR intervention.

Eligibility

Age

60 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Physician diagnosis of asthma
•Poorly controlled asthma, as evidenced by a score ≤ 19 on the Asthma Control Test
•Have a primary care provider willing to participate in the study by receiving email updates regarding the status of the participant

Exclusion Criteria

•Physician diagnosis of any other significant cardiopulmonary disease (including chronic obstructive pulmonary disease)
•A greater than 20 pack-year smoking history
•Lack of telephone access
•Decreased cognitive capacity such that participation in the program would not be possible

Locations (3)

University of Illinois-Chicago

Chicago, Illinois, United States

University of Michigan

Ann Arbor, Michigan, United States

University of Vermont

Burlington, Vermont, United States

Key Dates

Start Date

June 13, 2023

Primary Completion Date

May 14, 2024

Completion Date

May 31, 2024

Last Updated

July 1, 2024

Enrollment

ACTUAL participants

Conditions

Asthma

Interventions

SOAR intervention

BEHAVIORAL

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

NCT07219173

Asthma

View study

RECRUITINGNA

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NCT07486401

Asthma ExacerbationsBiomarkers / Blood+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 1, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Self-regulation for Older Adults With Asthma Through Remote Education

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma

To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma